Best Life Sciences Companies in Pleasanton, United States
The 53 best Life Sciences companies in Pleasanton, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Title21 Health Solutions.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Pleasanton
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Title21 Health Solutions Platform offering quality management solutions for health sciences organizations | $656M | 48 mo ago | 14 | 2001 | — | WordPressMySQLPHP+24 | — | 1 job opening · 4 launchs |
| 2 | 10X Genomics Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis | $243M | 90 mo ago | 961 | 2012 | Shawn Phillips | Cart FunctionalitySentryApple iCloud Mail+27 | 2,575 patents Single-cell and spatial multi-omics technologies for high-throughput nucleic acid analysis | — |
| 3 | UroLift Minimally invasive BPH treatment, improving men's urological health and quality of life | $196M | 150 mo ago | 49 | 2004 | — | HubSpot CMS HubSentryWistia+23 | — | — |
| 4 | Unchained Labs Developer of multiplex protein stability platform for biologics | $111M | 59 mo ago | 252 | 2015 | Tim Harkness Founder & CEO | WordPressMySQLPHP+19 | 67 patents Label-free interferometric detection and microfluidic analysis of nanoparticles and exosomes | — |
| 5 | IntegenX Rapid DNA identification solutions for forensics, law enforcement, and crime labs | $92M | 141 mo ago | 78 | 2006 | — | — | 236 patents Capillary microfluidic cartridges and devices for molecular sample analysis and electrophoresis | — |
| 6 | Purigen Biosystems Provider of isotachophoresis technology for nucleic acid sample preparation | $88M | 63 mo ago | 24 | 2012 | — | — | 51 patents Microfluidic isotachophoretic nucleic acid purification and specialized lysis buffer chemistries. | — |
| 7 | Calyxo Standalone nephrology hospital 69Funding top 19%Patents top 24%News top 25%Innovation top 31% All 9 signals ▾Fundingtop 19% Patentstop 24% Newstop 25% Innovationtop 31% Techtop 44% Moattop 44% Talentbottom 49% Marketbottom 47% Globalbottom 42% Funding: Raised $82.7M across 4 rounds · 4 rounds over 4 yrs (1.0/yr) Patents: 51 patents matched (strict assignee match) · 34 filings since 2022 vs 5 in 2017-21 rank vs industry peers · Fliar Intelligence Index 69/100 | $83M | 3 mo ago | 48 | 2016 | Joe Catanese President & CEO | WordPress Block EditorwpBakeryWordPress+35 | 51 patents Minimally invasive urological devices for kidney stone aspiration, irrigation, and catheter steering | 1 award |
| 8 | TriReme Medical Medical device for coronary disease | $58M | 163 mo ago | 2 | 2005 | — | — | — | — |
| 9 | Sanarus Provider of breast cryoblation procedure | $51M | 233 mo ago | 15 | 1999 | — | — | 12 patents Low‑pressure cryogenic probes for minimally invasive medical tissue ablation (fibroadenoma) | — |
| 10 | Spirosure Non-invasive breathalyzers for disease diagnosis and management | $41M | 102 mo ago | 12 | 2011 | Solomon Ssenyange Founder & Chairman | — | 29 patents Medical breath analysis and gas sensing devices for nitric oxide and respiratory monitoring | — |
| 11 | Apton Biosystems Developer of a sequencing-based molecular profiling platform | $35M | 60 mo ago | 15 | 2012 | — | — | 93 patents High‑throughput single‑molecule detection and densely‑packed analyte sequencing platforms | — |
| 12 | Movano Health Developer of radio frequency-enabled health monitoring devices and wearable technology | $30M | 27 mo ago | 27 | 2018 | John Mastrototaro CEO | WordPressMySQLPHP+16 | — | — |
| 13 | Quantalife Life science research and clinical diagnostics solutions provider, powering possibilities | $29M | 180 mo ago | 8 | 2008 | — | — | 45 patents Patents concentrated in chemistry & materials | — |
| 14 | Xradia Online sports betting and casino platform with diverse gaming options | $16M | 149 mo ago | 245 | 2000 | Rod Browning ex-CEO | — | 53 patents Advanced X-ray microscopy lenses, tomography, and non‑destructive IC inspection technologies | — |
| 15 | Primaeva Medical Aesthetic treatment devices for dermatologists and cosmetic surgeons | $14M | 208 mo ago | — | 2005 | — | — | — | — |
| 16 | Sandstone Diagnostics Provider of rapid test for sperm count | $12M | 86 mo ago | 14 | 2012 | — | — | 43 patents Portable point‑of‑care blood centrifugation and plasma separation devices for rapid diagnostics | — |
| 17 | Cerebrotech Medical Non-invasive & continuous monitoring for early detection of cerebral bleeding & edema | $6M | 122 mo ago | 8 | 2010 | Boris Rubinsky Co-Founder | — | — | — |
| 18 | Veeva Systems Veeva Systems is a provider of cloud-based business solutions for the global life sciences industry. | $4M | 217 mo ago | 6,744 | 2007 | — | WordPressProton MailGoogle Workspace+31 | 211 patents Cloud-based regulated content management and data querying for life sciences enterprise applications | 1 award |
| 19 | Graph Provider of an AI platform for patient safety and regulatory compliance | $3M | 9 mo ago | — | 2024 | Mohan K Chief Product Officer & Co-Founder | WordPressApple iCloud MailMicrosoft 365+26 | — | — |
| 20 | Astex Pharmaceuticals Oncology and CNS drug discovery and development using cutting-edge technology | $3M | 200 mo ago | 115 | 1991 | Harren Jhoti CEO & President | WordPressMySQLPHP+12 | 152 patents Small‑molecule oncology combos, LSD1 epigenetic inhibitors, and decitabine formulation technologies. | — |
| 21 | Integrated Dynamic Electron Solutions Developer of integrated dynamic electron solutions for transmission electron microscopes | $2M | 89 mo ago | 10 | 2009 | — | — | — | — |
| 22 | ConKay Medical Systems Provider of early-stage cardiovascular medical devices for valvular disease | $2M | 28 mo ago | 2 | 2020 | Albert Yuan Founder - President and CEO | — | — | — |
| 23 | Voxeleron AI-powered ophthalmic image analysis for breakthrough therapies and clinical trial management | $2M | 113 mo ago | 2 | 2010 | — | — | 28 patents AI-powered medical imaging analysis for disease diagnosis, corneal nerve segmentation, and tissue layer delineation. | — |
| 24 | InkSpace Imaging Developer of patent customized MRI coils | $100K | 57 mo ago | 11 11 → 23 (+109%) | 2016 | Michael Lusting Co-Founder | Wix eCommerceWixSentry+21 | 23 patents MRI coil and RF circuit designs for patient‑specific, high‑performance magnetic resonance imaging | 1 job opening |
Top 12 Life Sciences companies in Pleasanton
#1
Series F · Pleasanton, California · founded 2016 · 48 employees$82.7Mraised▾
Standalone nephrology hospital
- Apr 2026Series F$40.1M
- Dec 2024Series D$28.3M
- Oct 2023Series D$50M
- Feb 2022Series C$32.7M
#2
Seed · Pleasanton, California · founded 2024$3Mraised▾
Provider of an AI platform for patient safety and regulatory compliance. The platform unifies data sources, case processing, reporting, signal detection, risk management, and compliance. It offers ingestion, assimilation, and automation of adverse event information. The platform delivers audit-ready, explainable AI designed for regulatory confidence. It provides a knowledge graph and orchestrates AI reasoning through retrieval and workflow layers.
- Oct 2025Seed$3M
#3
Series D · Pleasanton, California · founded 2001 · 14 employees$656.3Mraised▾
Platform offering quality management solutions for health sciences organizations. The platform features include audit management, incident reporting, equipment maintenance, complaint management, OSHA reporting, competency management, CAPA management, and more.
- Jul 2022Series D$656.3M
#4
Public · Pleasanton, California · founded 2018 · 27 employees$30Mraised▾
Developer of radio frequency-enabled health monitoring devices and wearable technology. It focuses on creating devices for non-invasive blood pressure and glucose monitoring. The company designs technology for women's health, including a smart ring. It also conducts clinical studies related to its device development.
- Apr 2024Post IPO$24.1M
- Aug 2020Conventional Debt$2.5M
- Jul 2020Conventional Debt$10M
#5
Public · Pleasanton, California · founded 2012 · 961 employees$243Mraised▾
Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis. The company develops instruments, consumables, and software that enable researchers to profile up to a million cells, map RNA and proteins in tissues, and support multiomics workflows, with products cited in publications.
- Jan 2019Series D$85M
- Jan 2019Grant (prize money)$161.2K
- Apr 2018Venture Debt$75M
- Mar 2016Series C$55M
#6
Acquired · Pleasanton, California · founded 2015 · 252 employees$111Mraised▾
Developer of multiplex protein stability platform for biologics. The company offers Optim, a multiplex protein stability platform for biologics that lets researchers measure multiple protein stability parameters, including denaturing temperature and aggregation onset temperature on multiple samples simultaneously. The company’s Optim platform is used for various applications, such as lead candidate selection and optimization, pre-formulation studies, candidate formulation, and stability studies.
- Aug 2021Conventional Debt$155M
- May 2019Conventional Debt$50M
- Mar 2018Series D$17M
- Jun 2017Series C$13M
#7
Acquired · Pleasanton, California · founded 2012 · 24 employees$88.3Mraised▾
Purigen Biosystems is focused on nucleic acid sample prep by providing a platform based on the isotachophoresis technology. The technology was founded in the lab of Stanford University. It claims that the technology enables purification and quantitation of nucleic acid with increased yields and purity. Its automated benchtop instrumentation and accompanying microfluidic chip purify and quantitate nucleic samples from a wide variety of sources that includes even cancer samples. The purified DNA or RNA then has applications in downstream detection methods, including next-generation sequencing, PCR and other genomic tests.
- Apr 2021Series C$34.4M
- Jun 2019Series B$26.4M
- Jun 2018Series A$26.4M
- Mar 2016Grant (prize money)$150K
#8
Series D · Pleasanton, California · founded 2004 · 49 employees$195.6Mraised▾
Minimally invasive BPH treatment, improving men's urological health and quality of life. They offer a solution for Benign Prostatic Hyperplasia (BPH) using a minimally invasive approach. Their focus is on providing lasting relief from BPH symptoms, offering an alternative to medications or major surgery. The company provides resources for patients, including symptom scoring tools, physician finders, and FAQs. They are committed to improving the lives of men suffering from BPH by offering a treatment option that aims for rapid relief and recovery, with a focus on preserving sexual function. They provide educational resources, success stories, and access to trained physicians. Their business model is focused on medical devices and healthcare solutions, specifically addressing urological conditions.
- Jan 2014Series D$50.6M
- May 2012Series C$40.3M
- Feb 2011Series B$28.1M
- Jan 2011Series B$26M
#9
Acqui-Hired · Pleasanton, California · founded 2006 · 78 employees$92.1Mraised▾
Rapid DNA identification solutions for forensics, law enforcement, and crime labs. This company expedites crime-solving with rapid DNA technology, providing solutions for human identification in forensic settings. They offer products and services that enable faster DNA profiling, helping to identify suspects, reduce crime, and keep communities safe. Their offerings cater to investigators, police officers, DNA analysts, medical examiners, and criminal justice attorneys. The company's solutions increase lab efficiency, allowing forensic scientists to focus on complex cases. They provide tools for rapid investigative leads, disaster victim identification, and suspect identification at booking stations. Their technology is used by booking stations and accredited forensic DNA laboratories. They offer training, support, and resources to assist users in implementing and utilizing their rapid DNA solutions. This is a B2B company.
- Sep 2014Venture Debt$10M
- Dec 2012Series C$48.8M
- Dec 2011Conventional Debt$5M
- Jan 2011Series B$20.6M
#10
Series A · Pleasanton, California · founded 2012 · 15 employees$34.5Mraised▾
Developer of a sequencing-based molecular profiling platform. The platform is developing a high throughput system for the human genome sequence. The system can also analyze several proteins and nucleic acids. Also, it allows biomarker discovery, early disease detection, and therapeutic monitoring. It uses single-molecule detection technology that develops individual cancer biomarkers for the treatment of cancer.
- Jun 2021Series A$24M
- Nov 2015Series A$1M
- Oct 2015Series A$2.5M
- Mar 2015Series A$7M
#11
Public · Pleasanton, California · founded 2005 · 2 employees$57.6Mraised▾
TriReme Medical is a medical device company developing, manufacturing and distributing therapeutic solutions for minimally invasive coronary and peripheral devices for the treatment of vascular disease. It offers coronary stent systems, balloon catheters, and percutaneous transluminal coronary angioplasty balloon catheters for the treatment of coronary and peripheral arterial disease. TriReme Medical LLC operates as a subsidiary of QT Vascular Ltd.
- Nov 2012Series E$18M
- Oct 2010Series D$17M
- Nov 2009Series C$7.1M
- Oct 2007Series C$15.5M
#12
Seed · Pleasanton, California · founded 2020 · 2 employees$1.8Mraised▾
ConKay Medical Systems develops early-stage cardiovascular medical devices to treat valvular regurgitation in patients with progressive heart failure. It is also involved in the designing of medical devices. Its devices focused on treating the tricuspid valves. Its annular repair technology is designed to treat the main cause of functional regurgitation leaving the healthy leaflets intact to perform the way it was intended.
- Mar 2024Seed$1.8M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.